semustine has been researched along with fotemustine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boaziz, C; Breau, JL; Israël, L; Morere, JF | 1 |
| Ashby, J; Callander, RD; Shuker, DE; Tinwell, H; Vogel, EW | 1 |
| Kobiakov, GL | 1 |
2 review(s) available for semustine and fotemustine
| Article | Year |
|---|---|
[Brain metastases of malignant melanomas].
Topics: Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Carmustine; Dacarbazine; Humans; Interleukin-2; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds; Semustine | 1991 |
[Clinical significance of mustoforan in management of malignant glioma].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Disease-Free Survival; Female; Glioblastoma; Glioma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Nitrosourea Compounds; Oligodendroglioma; Organophosphorus Compounds; Semustine; Survival Analysis; Treatment Outcome | 2007 |
1 other study(ies) available for semustine and fotemustine
| Article | Year |
|---|---|
Mutagenicity to Salmonella, Drosophila and the mouse bone marrow of the human antineoplastic agent fotemustine: prediction of carcinogenic potency.
Topics: Animals; Antineoplastic Agents; Biological Assay; Bone Marrow; Carcinogenicity Tests; Carcinogens; Chromosome Deletion; Dose-Response Relationship, Drug; Drosophila melanogaster; Female; Male; Mice; Micronucleus Tests; Mutagenicity Tests; Mutagens; Nitrosourea Compounds; Organophosphorus Compounds; Predictive Value of Tests; Salmonella typhimurium; Semustine; X Chromosome | 1993 |